IL44127A - Imidazo(4,5-b)pyridines their preparation and pharmaceutical compositions containing them - Google Patents

Imidazo(4,5-b)pyridines their preparation and pharmaceutical compositions containing them

Info

Publication number
IL44127A
IL44127A IL44127A IL4412774A IL44127A IL 44127 A IL44127 A IL 44127A IL 44127 A IL44127 A IL 44127A IL 4412774 A IL4412774 A IL 4412774A IL 44127 A IL44127 A IL 44127A
Authority
IL
Israel
Prior art keywords
group
imidazo
phenyl
pyridine
general formula
Prior art date
Application number
IL44127A
Other languages
English (en)
Other versions
IL44127A0 (en
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2305339A external-priority patent/DE2305339C3/de
Priority claimed from DE2361757A external-priority patent/DE2361757A1/de
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of IL44127A0 publication Critical patent/IL44127A0/xx
Publication of IL44127A publication Critical patent/IL44127A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/75Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182Radicals derived from carboxylic acids
    • C07D295/192Radicals derived from carboxylic acids from aromatic carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/194Radicals derived from thio- or thiono carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D339/00Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02Five-membered rings
    • C07D339/06Five-membered rings having the hetero atoms in positions 1 and 3, e.g. cyclic dithiocarbonates

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
IL44127A 1973-02-03 1974-02-01 Imidazo(4,5-b)pyridines their preparation and pharmaceutical compositions containing them IL44127A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2305339A DE2305339C3 (de) 1973-02-03 1973-02-03 Imidazo [4,5-b] pyridine, ihre Herstellung und ihre Verwendung als Cardiötonica
DE2361757A DE2361757A1 (de) 1973-12-12 1973-12-12 Neue imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine

Publications (2)

Publication Number Publication Date
IL44127A0 IL44127A0 (en) 1974-05-16
IL44127A true IL44127A (en) 1977-05-31

Family

ID=25764640

Family Applications (1)

Application Number Title Priority Date Filing Date
IL44127A IL44127A (en) 1973-02-03 1974-02-01 Imidazo(4,5-b)pyridines their preparation and pharmaceutical compositions containing them

Country Status (24)

Country Link
JP (1) JPS5748556B2 (hu)
AT (1) AT332873B (hu)
BG (1) BG23902A3 (hu)
CA (1) CA1041502A (hu)
CH (1) CH605939A5 (hu)
CS (1) CS200169B2 (hu)
DD (1) DD108989A5 (hu)
DK (1) DK140760B (hu)
ES (1) ES422450A1 (hu)
FI (1) FI58126C (hu)
FR (1) FR2215968B1 (hu)
GB (1) GB1445824A (hu)
HK (1) HK4080A (hu)
HU (1) HU170909B (hu)
IE (1) IE39066B1 (hu)
IL (1) IL44127A (hu)
NL (1) NL173645C (hu)
NO (1) NO139386C (hu)
PH (1) PH14988A (hu)
PL (1) PL93127B1 (hu)
RO (2) RO84276B (hu)
SE (1) SE411451B (hu)
SU (2) SU563917A3 (hu)
YU (2) YU36955B (hu)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS49109394A (hu) * 1973-02-27 1974-10-17
DE3132754A1 (de) * 1981-08-19 1983-03-03 Merck Patent Gmbh, 6100 Darmstadt "2-aryl-imidazo(4,5-b)pyridine, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung"
ES8401486A1 (es) * 1981-11-10 1983-12-01 Wellcome Found Un procedimiento para la preparacion de nuevos derivados de imidazo (4,5-c)piridina.
ZA832938B (en) * 1982-05-03 1984-12-24 Lilly Co Eli 2-phenylimidazo(4,5-c)pyridines
US4772600A (en) * 1986-06-09 1988-09-20 A. H. Robins Company, Inc. Fused imidazoheterocyclic compounds and pharmaceutical compositions
JPH01190663A (ja) * 1988-01-22 1989-07-31 Terumo Corp システアミン誘導体及びこれを含有する抗リウマチ剤
US6653309B1 (en) 1999-04-26 2003-11-25 Vertex Pharmaceuticals Incorporated Inhibitors of IMPDH enzyme technical field of the invention
US9273027B2 (en) 2010-02-24 2016-03-01 Research Triangle Institute Arylpiperazine opioid receptor antagonists
BR122019003178B1 (pt) * 2010-12-24 2020-04-28 Sumitomo Chemical Co método de controle de pestes
WO2013191189A1 (ja) * 2012-06-21 2013-12-27 住友化学株式会社 縮合複素環化合物
CN104395300A (zh) 2012-06-22 2015-03-04 住友化学株式会社 稠合杂环化合物

Also Published As

Publication number Publication date
JPS49102693A (hu) 1974-09-27
YU36955B (en) 1984-08-31
FR2215968A1 (hu) 1974-08-30
NO139386B (no) 1978-11-20
SE411451B (sv) 1979-12-27
FI58126C (fi) 1980-12-10
SU634673A3 (ru) 1978-11-25
IE39066L (en) 1974-08-03
CS200169B2 (en) 1980-08-29
BG23902A3 (en) 1977-11-10
AU6512974A (en) 1975-08-07
FR2215968B1 (hu) 1977-01-28
NO740327L (no) 1974-08-06
YU17674A (en) 1982-06-18
IE39066B1 (en) 1978-08-02
HU170909B (hu) 1977-09-28
SU563917A3 (ru) 1977-06-30
ATA16474A (de) 1976-02-15
DD108989A5 (hu) 1974-10-12
CH605939A5 (hu) 1978-10-13
NL7401254A (hu) 1974-08-06
NO139386C (no) 1979-02-28
ES422450A1 (es) 1976-05-01
YU110480A (en) 1982-06-18
YU36956B (en) 1984-08-31
HK4080A (en) 1980-02-08
PH14988A (en) 1982-03-12
IL44127A0 (en) 1974-05-16
AT332873B (de) 1976-10-25
DK140760B (da) 1979-11-12
GB1445824A (en) 1976-08-11
PL93127B1 (hu) 1977-05-30
DK140760C (hu) 1980-04-21
NL173645C (nl) 1984-02-16
RO84276B (ro) 1984-07-30
JPS5748556B2 (hu) 1982-10-16
CA1041502A (en) 1978-10-31
FI58126B (fi) 1980-08-29
NL173645B (nl) 1983-09-16
RO79057A (ro) 1982-06-25
RO84276A (ro) 1984-05-23

Similar Documents

Publication Publication Date Title
CN102295642B (zh) 2-芳基咪唑并[1,2-a]吡啶-3-乙酰胺衍生物、其制备方法及用途
JP4145955B2 (ja) ピロロ〔2,3−d〕ピリミジン及びその使用
US3985891A (en) 2-Phenyl-imidazo (4,5-b)pyridines and salts thereof
FI79312B (fi) Foerfarande foer framstaellning av nya terapeutiskt anvaendbara 2-fenyl-1h-imidazo-/4,5-c/pyridiner och n-oxider och syra-additionssalter daerav.
US5614518A (en) Morpholine derivatives as dopamine receptor subtype ligands
JP2003528096A (ja) デカヒドロ−イソキノリン
IL44127A (en) Imidazo(4,5-b)pyridines their preparation and pharmaceutical compositions containing them
TWI336253B (en) Diazaindole-dicarbonyl-piperazinyl antiviral agents
PL125321B1 (en) Process for preparing novel,condensed derivatives of pyrimidines
US4110455A (en) 6-aryl-s-triazolo-(4,3-a)-pyrido-(2,3-f)-1,4-diazepines
CS207619B2 (en) Method of making the new derivatives of 5,11-dihydro-6h-pyrido 2,3-b 1,4 benzodiazepin-6-on
CS259516B2 (en) Method of new heterocyclic compounds production
FI92068C (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 7-fluori-4-okso-8-(1-piperatsinyyli)-1,4-dihydro-1,8-bentso/b/naftyridiini-3-karboksyylihappojen valmistamiseksi
JPH0441149B2 (hu)
US4465683A (en) Anti-psychotic agents
US4260612A (en) Antiallergic nitrogen bridge-head compounds
JPS63500518A (ja) 多環式キノリン、ナフチリジンおよびピラジノピリジン誘導体
DE2361757A1 (de) Neue imidazo eckige klammer auf 4,5-b eckige klammer zu pyridine
US4061632A (en) 3,11-Dihydro-6H-pyrazolo[1,5-a]pyrazolo[4',3':5,6]-pyrido[4,3-d]pyrimidin-6-one derivatives
JPS6130588A (ja) ベンゾ〔c〕〔1,8〕ナフチリジン、その製造方法及びその使用、並びにこれらの化合物を含有する調製剤
CS241026B2 (en) Method of pyrazolo(1,5-c)-quinozoline derivatives production
US4207322A (en) 6-Aryl-s-triazolo-(4,3-alpha)-pyrido-(2,3-f)-(1,4)-diazepines
JPS61129168A (ja) 2−(4−置換ピペラジン−4−オキシド−1−イル)−4−フエニルキノリン誘導体
IE43551B1 (en) Naphthyridine derivatives
CS244699B2 (cs) Způsob výroby v poloze 9 substituovaných derivátů 4-oxo-4H- -pyrido[1,2-a]-pyrimidinu